Home › CYTOPHIL, INC. › Implant Logistics Synthetic Biphasic Dental Bone Graft Granules
Implant Logistics Synthetic Biphasic Dental Bone Graft Granules
CYTOPHIL, INC. · Model 03-010-01-MIL · UDI-DI 00852108006114
LYC
Prescription
10
510(k) clearances
513
Adverse events (1 deaths)
14
Recalls
95
Facilities
Description
Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2018-08-16 | Collagen Matrix, Inc. | There is a possibility that the product was packaged in the wrong box. Specifically, the product may have been placed inside a BioMend box instead of a BioMend Extend box. The only |
| 2016-09-07 | Osteogenics Biomedical, Inc. | The device has the potential to be packaged in the wrong product box. |
| 2016-01-21 | Biomet France SARL | Cytotoxicity tests were not passed at 36 months. Use of Endobon-Xenograft Granules past 18 months of its specified shelf life may result in patient illness/injury. |
| 2013-10-03 | Biomet 3i, LLC | Individual pieces of a batch of Biomet's Endobon Xenograft Granules 0.5 ML (Bovine Bone substitute) may have an incorrect label with the wrong batch number. |
| 2013-03-28 | Integra LifeSciences Corporation | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products. |
| 2013-03-28 | Integra LifeSciences Corporation | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products. |
| 2013-03-28 | Integra LifeSciences Corporation | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products. |
| 2012-10-25 | Kerr Corporation | The firm initiated the recall becaue disturbing the BioPlant product soon after it is placed may halt or delay the ossification process. |
| 2012-01-11 | Cytophil, Inc | Cytophil Corporation is recalling Periophil Biphasic Periophil Biphasic, Periobase Biphasic, and Periobone Biphasic because devices were inadvertently shipped after receiving an in |
| 2010-05-14 | Ace Surgical Supply Co., Inc. | Fast set 4% potassium sulfate solution may not be sterile. For customers who have used the Calcium Sulfate Hemihydrate kit without the Fast Set solution, then these potential risk |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
